TABLE 1
FROM:
Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury
C M Bernards and T Akers
BACK TO ARTICLETable 1. Pharmacokinetic parameters
| Sampling site | Group | ||
|---|---|---|---|
| Saline | Intravenous methylprednisolone | Intrathecal methylprednisolone | |
| CSF at injury site | |||
| Peak concentration (fractions of baseline) | |||
| Aspartate | 3.3 1.7 | 4.8 2.6 | 4.6 3.8 |
| Glutamate | 2.6 1.2 | 3.3 1.5 | 3.1 1.6 |
| Citrulline | 1.9 0.4 | 2.2 0.7 | 1.9 0.7 |
| PGE2 | 9.5 8.7 | 10.8 8.6 | 10.5 10.6 |
| Time to peak concentration (min) | |||
| Aspartate | 146 28 | 138 9.5 | 158 56 |
| Glutamate | 145 21 | 140 10 | 153 45 |
| Citrulline | 230 72 | 272 86 | 237 85 |
| PGE2 | 157 43 | 188 84 | 140 7.5 |
AUC (fraction of baseline time)
| |||
| Aspartate | 389 194 | 385 118 | 408 192 |
| Glutamate | 324 167 | 308 82 | 332 176 |
| Citrulline | 353 109 | 378 152 | 344 131 |
| PGE2 | 448 239 | 530 263 | 559 255 |
| CSF at proximal control site | |||
| Peak concentration (fraction of baseline) | |||
| Aspartate | 2.0 0.8 | 2.5 2.1 | 2.4 1.6 |
| Glutamate | 1.9 1.0 | 2.7 2.0 | 2.0 1.4 |
| Citrulline | 1.7 0.5 | 1.8 0.8 | 1.7 0.6 |
| PGE2 | 1.7 1.3 | 4.7 5.8 | 3.5 2.5 |
| Time to peak concentration (min) | |||
| Aspartate | 248 82 | 245 82 | 234 84 |
| Glutamate | 251 88 | 259 99 | 193 67 |
| Citrulline | 236 66 | 311 74 | 254 83 |
| PGE2 | 183 66 | 178 70 | 195 80 |
AUC (fraction of baseline time)
| |||
| Aspartate | 277 81 | 264 124 | 291 132 |
| Glutamate | 296 127 | 317 164 | 293 154 |
| Citrulline | 300 64 | 305 95 | 309 82 |
| PGE2 | 195 101 | 266 154 | 394 433 |

1.7
time)